Repeated Intravitreal Injection of Triamcinolone for Exudative Age-Related Macular Degeneration

Publisher： Karger

E-ISSN： 1423-0259|38|6|324-328

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.38, Iss.6, 2006-11, pp. : 324-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Bevacizumab versus Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 41, Iss. 1, 2008-10 ,pp. : 21-27

Karger

Access to resources Recommend Favorite

Intravitreal Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration among Japanese Patients

By  

Ophthalmologica, Vol. 220, Iss. 2, 2006-02 ,pp. : 118-124

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab and Bevacizumab in Combination with Full-Fluence Verteporfin Therapy and Dexamethasone for Exudative Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 45, Iss. 3, 2010-09 ,pp. : 129-134

Karger

Access to resources Recommend Favorite

The Effect of Intravitreal Ranibizumab on the Fellow Untreated Eye with Subfoveal Scarring due to Exudative Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 223, Iss. 6, 2009-07 ,pp. : 383-389

Karger

Access to resources Recommend Favorite